Has Martin Ferrillo, DO received payments from drug or device companies?

Yes. Drug and device makers reported $164,272 in general payments to Martin Ferrillo, DO across 1,017 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Martin Ferrillo, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Martin Ferrillo, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Martin Ferrillo, DO

Interventional Pain Medicine · Albany, NYNPI 1598725673

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (41.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by Boston Scientific at 58.0% of the total. 2025 is the largest year on record at $41,193, 2.5 times the $16,212 reported in 2019. Among interventional pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$164,272in general payments, 2019–2025

Across 1,017 payments — averaging $161.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$95K
Pacira Pharmaceuticals Incorporated$54K
Medtronic$2K
Relievant Medsystems, Inc.$2K
Nevro Corp.$2K
Spinal Simplicity, LLC$1K
plus $9K from 38 others

What the payments were for

Consulting fees$41,00525%
Speaking & faculty fees$67,33541%
Travel & lodging$20,82513%
Food & beverage$35,10721%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	605	$95,256
Pacira Pharmaceuticals Incorporated	85	$53,716
Medtronic(2 entities)	16	$1,798
Relievant Medsystems, Inc.	18	$1,754
Nevro Corp.	44	$1,573
Spinal Simplicity, LLC	10	$1,363
AbbVie(2 entities)	50	$1,117
Nalu Medical, Inc.	8	$969
Abbott	16	$895
Vertos Medical, Inc.	21	$892
Si-bone, Inc.	14	$797
Saluda Medical Americas, Inc.	11	$642
SPR Therapeutics, Inc	21	$350
Scilex Pharmaceuticals Inc.	4	$335
Painteq LLC	4	$307
Johnson & Johnson	8	$274
Arthrex	4	$272
Pfizer	13	$252
Fidia Pharma USA Inc.	12	$205
Novo Nordisk	2	$145
Vertex	7	$142
Acelrx Pharmaceuticals, Inc.	2	$113
International Rehabilitative Sciences, Inc	3	$102
Lilly USA, LLC	4	$101
Curonix LLC	1	$98
Bioventus LLC	4	$97
Biohaven Pharmaceuticals, Inc.	2	$94
Trice Medical, Inc.	1	$77
Ipsen Biopharmaceuticals, Inc	4	$73
Amgen	4	$66
Stryker	3	$64
Prodigy Surgical Distribution, Inc.	1	$61
IBSA Pharma Inc.	3	$48
Collegium Pharmaceutical, Inc.	2	$34
Biogen	1	$24
Pacira Therapeutics, Inc.	1	$23
Lundbeck LLC	1	$23
Biohaven Pharmaceutical Holding Company Ltd.	1	$20
Biotronik NRO, Inc.	1	$20
Kowa Pharmaceuticals America, Inc.	1	$19
Azurity Pharmaceuticals, Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$17
MML US, Inc.	1	$15
Foundation Fusion Solutions, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Iovera$43,727
WaveWriter Alpha Prime 16$24,110
Zilretta$17,274
GENERAL PAIN MANAGEMENT$17,195
EXPAREL$13,789
WAVEWRITER ALPHA$13,034
GENERAL - THERAPIES$8,242
SPECTRA WAVEWRITER$6,928
Intracept$3,372
IOVERA SYSTEM$1,654
VERIFLEX$1,600
KYPHON EXPRESS II KYPHOPAK TRAY$1,230
HA MINUTEMAN G3-R$1,056
Nalu Neurostimulation System$819
Senza Spinal Cord Stimulation System$515
LIBERTY SI$329
Superion Indirect Decompression System$322
SUPERION$322
Evoke$298
ZTLido$287

How this compares

$164,272 in reported general payments places this provider in the 95th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York →

Medicare billing

Part B allowed, 2024

$798,412

Medicare patients

961

Services billed

25,035

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Albany

Amar ParikhAlbany$28K
Edward ApicellaAlbany$13K
Farrukh AnsariAlbany$6K
Corey HunterNew York$446K
Neel MehtaNew York$432K
Hemant KaliaRochester$179K
George ChaseKew Gardens$102K
Kimberly SackheimNew York$102K
Suelane OuroNew York$68K
Gerard DegregorisNew York$49K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →